INDIANOLA, Pa., Dec. 14 /PRNewswire-FirstCall/ -- Readers of Medical Imaging Magazine again ranked MEDRAD, INC. among the top five in two out of three categories in its 2005 Readers’ Choice Awards, alongside industry leaders GE Healthcare, Philips Medical Systems, Siemens Medical Solutions and Eastman Kodak Co.
(Logo: http://www.newscom.com/cgi-bin/prnh/20040309/MEDRADLOGO)
MEDRAD tied for fifth place in the Manufacturing category, and moved up a ranking to fourth place in Accessories/Supplies/Service. The third category was Dealer/Distributor and Remanufacturer/Rebuilder. Readers were asked to pick the top companies in each category based on excellence in quality, price, training, service and integration. The full report is available at http://www.medicalimagingmag.com/issues/articles/2005-12_01.asp.
“This recognition is a key indicator that we are consistently delivering the performance that our customers value and recognize,” according to MEDRAD President and CEO John P. Friel. “We are committed to building a quality organization at every level, and our customers continue to reward our efforts.”
MEDRAD, INC. is a worldwide leading provider of medical devices and services that enable and enhance imaging procedures of the human body. Used in diagnostic imaging, MEDRAD’s product offerings include a comprehensive line of vascular injection systems, magnetic resonance (MR) surface coils and patient care products, and equipment services. Total 2004 revenues were $343 million. MEDRAD is a 2003 recipient of the Malcolm Baldrige National Quality Award, the top honor a U.S. company can receive for quality and business excellence. The company’s world headquarters is near Pittsburgh, Pennsylvania, in the United States. MEDRAD is a U.S. affiliate of Schering AG, Germany . For more information, visit MEDRAD’s website at www.medrad.com.
Cautionary statement regarding forward-looking statements.
Certain statements in this press release that are neither reported financial results nor other historical information are forward-looking statements, including but not limited to, statements that are predictions of or indicate future events, trends, plans or objectives. Undue reliance should not be placed on such statements because, by their nature, they are subject to known and unknown risks and uncertainties and can be affected by other factors that could cause actual results and MEDRAD’s plans and objectives to differ materially from those expressed or implied in the forward-looking statements. MEDRAD undertakes no obligation to update publicly or revise any of these forward-looking statements, whether to reflect new information or future events, circumstances or otherwise.
Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20040309/MEDRADLOGOAP Archive: http://photoarchive.ap.orgPRN Photo Desk, photodesk@prnewswire.comMEDRAD, INC.
CONTACT: Luanne Radermacher, Corporate Affairs of MEDRAD, INC.,+1-412-767-2400 ext. 3184, or lradermacher@medrad.com
Web site: http://www.medrad.com//
